Photo of Kevin Winthrop, M.D., M.P.H.

Kevin Winthrop M.D., M.P.H.

Dr. Winthrop specializes in international ophthalmology, public health and infectious disease epidemiology with an emphasis in mycobacterial diseases and opportunistic infections associated with rheumatic disease and immunosuppressive therapies. He has a special focus in:

Chronic chest infections of all etiology, including mycobacteria The prevention and treatment of infections associated with Biologics and other Immunosuppressive therapies Tuberculosis of the eye (Ophthalmology)

Read more

Education

  • M.D., Oregon Health & Science University, Portland Oregon 1998
  • M.P.H., Univerisity of California at Berkeley, Berkeley California 2003
  • Residency:

    • Stanford University
    • Legacy Emanuel Health Systems, Portland, Oregon
  • Fellowship:

    • National Jewish Medical Center, Denver, Colorado
    • US Centers for Disease Control and Prevention (CDC)

Publications

  • "Interventions to reduce inappropriate prescribing of antibiotics for acute respiratory tract infections : summary and update of a systematic review." Journal of International Medical Research In: , Vol. 46, No. 8, 01.08.2018, p. 3337-3357.
  • "Multicenter study of QuantiFERON®-TB Gold Plus in patients with active tuberculosis." International Journal of Tuberculosis and Lung Disease In: , Vol. 22, No. 6, 01.06.2018, p. 617-621.
  • "Impact of temporary methotrexate discontinuation for 2 weeks on immunogenicity of seasonal influenza vaccination in patients with rheumatoid arthritis : A randomised clinical trial." Annals of the Rheumatic Diseases  In: , Vol. 77, No. 6, 01.06.2018, p. 898-904.
  • "Epidemiology of nontuberculous mycobacterial infections in the U.S. Veterans Health Administration." PLoS One In: , Vol. 13, No. 6, 0197976, 01.06.2018.
  • "Pneumocystis and glucocorticoid use : To prophylax or not to prophylax (and when?); That is the question." Annals of the Rheumatic Diseases In: , Vol. 77, No. 5, 01.05.2018, p. 631-633.
  • "The prevalence and significance of Staphylococcus aureus in patients with non-cystic fibrosis bronchiectasis." Annals of the American Thoracic Society  In: , Vol. 15, No. 3, 01.03.2018, p. 365-370.
  • "T-cell–mediated immune response to pneumococcal conjugate vaccine (PCV-13) and tetanus toxoid vaccine in patients with moderate-to-severe psoriasis during tofacitinib treatment." Journal of the American Academy of Dermatology  In: , 01.01.2018.
  • "ESCMID Study Group for Infections in Compromised Hosts (ESGICH) Consensus Document on the safety of targeted and biological therapies : An infectious diseases perspective (Soluble immune effector molecules [II]: Agents targeting interleukins, immunoglobulins and complement factors)." Clinical Microbiology and Infection In: , 01.01.2018.
  • "Mycobacterial Disease : Evolving Concepts." Seminars in Respiratory and Critical Care Medicine In: , Vol. 39, No. 3, 01.01.2018.
  • "Treatment of Mycobacterium abscessus Complex." Seminars in Respiratory and Critical Care Medicine In: , Vol. 39, No. 3, 01.01.2018, p. 362-376.
  • "Use of a baseline risk score to identify the risk of serious infectious events in patients with rheumatoid arthritis during certolizumab pegol treatment." Arthritis Research and Therapy  In: , Vol. 19, No. 1, 276, 15.12.2017.
  • "Pharmacotherapy for Non-Cystic Fibrosis Bronchiectasis : Results From an NTM Info & Research Patient Survey and the Bronchiectasis and NTM Research Registry." Chest In: , Vol. 152, No. 6, 01.12.2017, p. 1120-1127.
  • "Surveillance of extrapulmonary nontuberculous mycobacteria infections, Oregon, USA, 2007–2012." Emerging Infectious Diseases In: , Vol. 23, No. 10, 01.10.2017, p. 1627-1630.
  • "Effect of methotrexate discontinuation on efficacy of seasonal influenza vaccination in patients with rheumatoid arthritis : a randomised clinical trial." Annals of the Rheumatic Diseases  In: , Vol. 76, No. 9, 01.09.2017, p. 1559-1565.
  • "Herpes zoster in psoriasis patients treated with tofacitinib." Journal of the American Academy of Dermatology  In: , Vol. 77, No. 2, 01.08.2017, p. 302-309.
  • "Frequency of untreated hypogammaglobulinemia in bronchiectasis." Annals of Allergy, Asthma and Immunology In: , Vol. 119, No. 1, 01.07.2017, p. 83-85.
  • "The role of IL-6 in host defence against infections : Immunobiology and clinical implications." Nature Reviews Rheumatology  In: , Vol. 13, No. 7, 01.07.2017, p. 399-409.
  • "Pharmacotherapy : Biosimilar switching-"To set a form upon desired change"." Nature Reviews Rheumatology In: , Vol. 13, No. 7, 01.07.2017, p. 391-392.
  • "Long-term safety of tofacitinib for the treatment of rheumatoid arthritis up to 8.5 years : Integrated analysis of data from the global clinical trials." Annals of the Rheumatic Diseases  In: , Vol. 76, No. 7, 01.07.2017, p. 1253-1262.
  • "The RESPIRE trials : Two phase III, randomized, multicentre, placebo-controlled trials of Ciprofloxacin Dry Powder for Inhalation (Ciprofloxacin DPI) in non-cystic fibrosis bronchiectasis." Contemporary Clinical Trials  In: , Vol. 58, 01.07.2017, p. 78-85.
  • "Long-term outcomes in a population-based cohort with respiratory nontuberculous mycobacteria isolation." Annals of the American Thoracic Society In: , Vol. 14, No. 7, 01.07.2017, p. 1120-1128.
  • "Mortality after respiratory isolation of nontuberculous mycobacteria a comparison of patients who did and did not meet disease criteria." Annals of the American Thoracic Society In: , Vol. 14, No. 7, 01.07.2017, p. 1112-1119.
  • "Longterm effectiveness of herpes zoster vaccine among patients with autoimmune and inflammatory diseases." Journal of Rheumatology In: , Vol. 44, No. 7, 01.07.2017, p. 1083-1087.
  • "Adult Patients With Bronchiectasis : A First Look at the US Bronchiectasis Research Registry." Chest  In: , Vol. 151, No. 5, 01.05.2017, p. 982-992.
  • "Safety of biologic and nonbiologic disease-modifying antirheumatic drug therapy in veterans with rheumatoid arthritis and hepatitis c virus infection." Journal of Rheumatology In: , Vol. 44, No. 5, 01.05.2017, p. 565-570.
  • "The emerging safety profile of JAK inhibitors in rheumatic disease." Nature Reviews Rheumatology In: , Vol. 13, No. 4, 01.04.2017, p. 234-243.
  • "Randomized trial of liposomal amikacin for inhalation in nontuberculous mycobacterial lung disease." American Journal of Respiratory and Critical Care Medicine In: , Vol. 195, No. 6, 15.03.2017, p. 814-823.
  • "Pulmonary nontuberculous mycobacteria-associated deaths, Ontario, Canada, 2001-2013." Emerging Infectious Diseases In: , Vol. 23, No. 3, 01.03.2017, p. 468-476.
  • "Disseminated nontuberculous mycobacteria in HIV-infected patients, Oregon, USA, 2007–2012." Emerging Infectious Diseases In: , Vol. 23, No. 3, 01.03.2017, p. 533-535.
  • "On the reportability of nontuberculous mycobacterial disease to public health authorities." Annals of the American Thoracic Society  In: , Vol. 14, No. 3, 01.03.2017, p. 314-317.

Additional information

Edit profile